281 related articles for article (PubMed ID: 29277621)
21. Mortality attributable to cholestatic liver disease in the United States.
Mendes FD; Kim WR; Pedersen R; Therneau T; Lindor KD
Hepatology; 2008 Apr; 47(4):1241-7. PubMed ID: 18318437
[TBL] [Abstract][Full Text] [Related]
22. Geoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland.
Terziroli Beretta-Piccoli B; Stirnimann G; Cerny A; Semela D; Hessler R; Helbling B; Stickel F; Kalid-de Bakker C; Bihl F; Giostra E; Filipowicz Sinnreich M; Oneta C; Baserga A; Invernizzi P; Carbone M; Mertens J
Clin Rev Allergy Immunol; 2018 Apr; 54(2):295-306. PubMed ID: 29181702
[TBL] [Abstract][Full Text] [Related]
23. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.
Charatcharoenwitthaya P; Pimentel S; Talwalkar JA; Enders FT; Lindor KD; Krom RA; Wiesner RH
Liver Transpl; 2007 Sep; 13(9):1236-45. PubMed ID: 17763401
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and incidence of primary biliary cirrhosis are increasing in Finland.
Rautiainen H; Salomaa V; Niemelå S; Karvonen AL; Nurmi H; Isoniemi H; Färkkilä M
Scand J Gastroenterol; 2007 Nov; 42(11):1347-53. PubMed ID: 17918011
[TBL] [Abstract][Full Text] [Related]
25. Underestimated Male Prevalence of Primary Biliary Cholangitis in China: Results of a 16-yr cohort study involving 769 patients.
Fan X; Wang T; Shen Y; Xi X; Yang L
Sci Rep; 2017 Jul; 7(1):6560. PubMed ID: 28747696
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology and natural history of primary biliary cirrhosis in a US community.
Kim WR; Lindor KD; Locke GR; Therneau TM; Homburger HA; Batts KP; Yawn BP; Petz JL; Melton LJ; Dickson ER
Gastroenterology; 2000 Dec; 119(6):1631-6. PubMed ID: 11113084
[TBL] [Abstract][Full Text] [Related]
27. Transplantation trends in primary biliary cirrhosis.
Lee J; Belanger A; Doucette JT; Stanca C; Friedman S; Bach N
Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1313-5. PubMed ID: 17900996
[TBL] [Abstract][Full Text] [Related]
28. Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy.
Lammers WJ; Hirschfield GM; Corpechot C; Nevens F; Lindor KD; Janssen HL; Floreani A; Ponsioen CY; Mayo MJ; Invernizzi P; Battezzati PM; Parés A; Burroughs AK; Mason AL; Kowdley KV; Kumagi T; Harms MH; Trivedi PJ; Poupon R; Cheung A; Lleo A; Caballeria L; Hansen BE; van Buuren HR;
Gastroenterology; 2015 Dec; 149(7):1804-1812.e4. PubMed ID: 26261009
[TBL] [Abstract][Full Text] [Related]
29. Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis.
Umemura T; Sekiguchi T; Joshita S; Yamazaki T; Fujimori N; Shibata S; Ichikawa Y; Komatsu M; Matsumoto A; Shums Z; Norman GL; Tanaka E; Ota M
Liver Int; 2017 Jun; 37(6):897-905. PubMed ID: 27860118
[TBL] [Abstract][Full Text] [Related]
30. Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival.
Montano-Loza AJ; Hansen BE; Corpechot C; Roccarina D; Thorburn D; Trivedi P; Hirschfield G; McDowell P; Poupon R; Dumortier J; Bosch A; Giostria E; Conti F; Parés A; Reig A; Floreani A; Russo FP; Goet JC; Harms MH; van Buuren H; Van den Ende N; Nevens F; Verhelst X; Donato MF; Malinverno F; Ebadi M; Mason AL;
Gastroenterology; 2019 Jan; 156(1):96-107.e1. PubMed ID: 30296431
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune liver diseases in the Asia-Pacific region: Proceedings of APASL symposium on AIH and PBC 2016.
Tanaka A; Ma X; Yokosuka O; Weltman M; You H; Amarapurkar DN; Kim YJ; Abbas Z; Payawal DA; Chang ML; Efe C; Ozaslan E; Abe M; Mitchell-Thain R; Zeniya M; Han KH; Vierling JM; Takikawa H
Hepatol Int; 2016 Nov; 10(6):909-915. PubMed ID: 27649967
[TBL] [Abstract][Full Text] [Related]
32. Primary biliary cirrhosis in Estonia. With special reference to incidence, prevalence, clinical features, and outcome.
Remmel T; Remmel H; Uibo R; Salupere V
Scand J Gastroenterol; 1995 Apr; 30(4):367-71. PubMed ID: 7610354
[TBL] [Abstract][Full Text] [Related]
33. Population-based epidemiology of primary biliary cirrhosis in South Korea.
Kim KA; Ki M; Choi HY; Kim BH; Jang ES; Jeong SH
Aliment Pharmacol Ther; 2016 Jan; 43(1):154-62. PubMed ID: 26526639
[TBL] [Abstract][Full Text] [Related]
34. Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid.
Angulo P; Lindor KD; Therneau TM; Jorgensen RA; Malinchoc M; Kamath PS; Dickson ER
Liver; 1999 Apr; 19(2):115-21. PubMed ID: 10220741
[TBL] [Abstract][Full Text] [Related]
35. Increased risk of osteoporosis in patients with primary biliary cirrhosis.
Liao CY; Chung CH; Chu P; Wei KY; Feng TM; Lin FH; Tsao CH; Wu CC; Chien WC
PLoS One; 2018; 13(3):e0194418. PubMed ID: 29543880
[TBL] [Abstract][Full Text] [Related]
36. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation.
Kim WR; Poterucha JJ; Jorgensen RA; Batts KP; Homburger HA; Dickson ER; Krom RA; Wiesner RH; Lindor KD
Hepatology; 1997 Jul; 26(1):22-6. PubMed ID: 9214447
[TBL] [Abstract][Full Text] [Related]
37. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population.
Boberg KM; Aadland E; Jahnsen J; Raknerud N; Stiris M; Bell H
Scand J Gastroenterol; 1998 Jan; 33(1):99-103. PubMed ID: 9489916
[TBL] [Abstract][Full Text] [Related]
38. Predictive scores in primary biliary cirrhosis: a retrospective single center analysis of 204 patients.
Weinmann A; Sattler T; Unold HP; Grambihler A; Teufel A; Koch S; Schuchmann M; Biesterfeld S; Wörns MA; Galle PR; Schulze-Bergkamen H
J Clin Gastroenterol; 2015; 49(5):438-47. PubMed ID: 25014239
[TBL] [Abstract][Full Text] [Related]
39. Rising incidence and prevalence of primary biliary cirrhosis: a large population-based study.
Boonstra K; Kunst AE; Stadhouders PH; Tuynman HA; Poen AC; van Nieuwkerk KM; Witteman EM; Hamann D; Witteman BJ; Beuers U; Ponsioen CY;
Liver Int; 2014 Jul; 34(6):e31-8. PubMed ID: 24387641
[TBL] [Abstract][Full Text] [Related]
40. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid.
Kuiper EM; Hansen BE; de Vries RA; den Ouden-Muller JW; van Ditzhuijsen TJ; Haagsma EB; Houben MH; Witteman BJ; van Erpecum KJ; van Buuren HR;
Gastroenterology; 2009 Apr; 136(4):1281-7. PubMed ID: 19208346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
